SCHEMBL7497784

SCHEMBL7497784

CCCCCCCCCCCCCCC(O)CNCCCNCCCCN

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GNAI3 P08754 1/20 0.48
GNAO1 P09471 1/20 0.48
GNAI1 P63096 1/20 0.48
RELA Q04206 4/20 0.44
ANPEP P15144 1/20 0.44
ERAP2 Q6P179 1/20 0.44
SIRT6 Q8N6T7 1/20 0.43
SIRT1 Q96EB6 1/20 0.43
DNM1 Q05193 7/20 0.42
TSHR P16473 3/20 0.42
ALDH1A1 P00352 2/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
EPHX1 P07099 1/20 0.42
CA12 O43570 1/20 0.41
F13A1 P00488 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CYP1A2 P05177 1/20 0.41
CA3 P07451 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7095309 1.00 GNAI3 (0.48) GNAI3GNAO1GNAI1RELAANPEP
SCHEMBL7093133 1.00 GNAI3 (0.48) GNAI3GNAO1GNAI1RELAANPEP
Hydrochloric Acid SCHEMBL7096803 0.98 GNAI3 (0.47) GNAI3GNAO1GNAI1RELAANPEP
SCHEMBL6825299 0.98 GNAI3 (0.49) GNAI3GNAO1GNAI1RELAANPEP
SCHEMBL27591426 0.97 RELA (0.48) GNAI3GNAO1GNAI1RELAANPEP
SCHEMBL27591629 0.97 RELA (0.48) GNAI3GNAO1GNAI1RELAANPEP
SCHEMBL7092727 0.97 RELA (0.48) GNAI3GNAO1GNAI1RELAANPEP
SCHEMBL9705885 0.97 GNAI3 (0.50) GNAI3GNAO1GNAI1ANPEPERAP2
Oxalic Acid SCHEMBL7097314 0.93 GNAI3 (0.49) GNAI3GNAO1GNAI1RELAANPEP
SCHEMBL10382687 0.92 SPHK1 (0.44) GNAI3GNAO1GNAI1RELAANPEP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1242609-A2 NOVEL COLLOID SYNTHETIC VECTORS FOR GENE THERAPY Novartis AG (CH) 2002-09-25 EP disclosed
WO-2001049324-A2 NOVEL COLLOID SYNTHETIC VECTORS FOR GENE THERAPY NOVARTIS AG (CH) 2001-07-12 WO disclosed